Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

SHA:600664 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3,182	3,437	3,634	3,060	2,433	1,592
Cash & Short-Term Investments	3,182	3,437	3,634	3,060	2,433	1,592
Cash Growth	13.55%	-5.44%	18.75%	25.76%	52.85%	77.49%
Accounts Receivable	5,235	4,748	4,985	4,961	4,818	4,749
Other Receivables	140.08	129.57	130.8	146.47	178.51	85.86
Receivables	5,375	4,878	5,116	5,107	4,997	4,835
Inventory	2,161	2,061	1,891	1,924	1,804	2,064
Prepaid Expenses	-	6.82	9.67	10.7	4.93	-
Other Current Assets	319.27	270.93	327.8	293.61	320.05	242.45
Total Current Assets	11,038	10,653	10,979	10,396	9,560	8,733
Property, Plant & Equipment	2,313	2,338	2,385	2,468	2,641	2,835
Long-Term Investments	31.06	31.06	33.49	38.42	37.62	39.32
Goodwill	39.16	39.16	39.16	39.15	39.15	39.15
Other Intangible Assets	407.58	411.55	408.4	451.14	444.21	480.78
Long-Term Deferred Tax Assets	614.33	607.84	603.74	597.85	600.19	599.44
Long-Term Deferred Charges	90.79	88.53	63.4	41.29	63.96	71.76
Other Long-Term Assets	118.59	118.59	104.24	80.16	48.84	44.11
Total Assets	14,653	14,288	14,616	14,112	13,435	12,842

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4,231	4,032	4,039	3,951	3,510	3,482
Accrued Expenses	483.69	602.44	618.37	597.07	668.02	628.3
Short-Term Debt	1,021	1,041	1,554	1,658	1,933	2,078
Current Portion of Long-Term Debt	139.29	105.47	104.76	104.04	103.64	102.92
Current Portion of Leases	-	27.76	36.23	31.21	35.93	36.74
Current Income Taxes Payable	137.41	43.91	57.21	80.1	98.29	85.17
Current Unearned Revenue	114.31	130.74	311.61	282.45	235.87	119.73
Other Current Liabilities	1,484	1,439	1,383	1,539	1,417	1,322
Total Current Liabilities	7,611	7,423	8,105	8,243	8,002	7,855
Long-Term Debt	31.48	31.48	31.7	32.63	33.19	34.09
Long-Term Leases	27.91	30.16	35.32	31.08	43.68	61.61
Long-Term Unearned Revenue	296.53	290.97	300.74	319.07	333.61	375.1
Long-Term Deferred Tax Liabilities	7.24	7.59	5.73	6.91	6.29	1.68
Other Long-Term Liabilities	42.78	42.78	47.98	56.64	69.7	94.7
Total Liabilities	8,016	7,826	8,526	8,689	8,488	8,422

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2,519	2,519	2,519	2,521	2,526	2,518
Additional Paid-In Capital	674.09	663.33	684.11	685.32	688.6	675.43
Retained Earnings	4,433	4,272	3,911	3,282	2,887	2,426
Treasury Stock	-	-	-	-3.98	-13.01	-15.53
Comprehensive Income & Other	-1,766	-1,766	-1,763	-1,760	-1,760	-1,757
Total Common Equity	5,860	5,688	5,350	4,724	4,328	3,847
Minority Interest	776.08	774	739.49	698.75	618.87	573.25
Shareholders' Equity	6,636	6,462	6,089	5,423	4,947	4,420
Total Liabilities & Equity	14,653	14,288	14,616	14,112	13,435	12,842

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,220	1,236	1,762	1,857	2,149	2,313
Net Cash (Debt)	1,962	2,201	1,872	1,203	284.1	-720.94
Net Cash Growth	35.57%	17.58%	55.56%	323.57%	-	-
Net Cash Per Share	0.76	0.85	0.74	0.49	0.11	-0.29
Filing Date Shares Outstanding	2,519	2,519	2,519	2,521	2,526	2,518
Total Common Shares Outstanding	2,519	2,519	2,519	2,521	2,526	2,518
Working Capital	3,427	3,230	2,874	2,153	1,558	878.23
Book Value Per Share	2.33	2.26	2.12	1.87	1.71	1.53
Tangible Book Value	5,413	5,237	4,902	4,234	3,844	3,327
Tangible Book Value Per Share	2.15	2.08	1.95	1.68	1.52	1.32
Buildings	-	4,603	4,659	4,644	4,702	4,683
Machinery	-	3,362	3,308	3,214	3,169	3,545
Construction In Progress	-	65.56	74.73	69.12	66.22	164.92

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error